G2GBIO
₩32,450
1
-₩3,750-10.36% 06:30 Today
Statistics
Day High
35,700
Day Low
32,100
52W High
124,000
52W Low
22,400
Volume
291,381
Avg. Volume
274,777
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
G2GBIO Inc., a clinical-stage biotech company, provides pharmaceutical products. The company's pipeline products include GB-5001, GB-5001A, and GB-5112 for the treatment of Alzheimer's disease; GB-6002, an opioid drug that is used for post-operative pain treatment; GB-7001 for type-2 diabetes treatments; GB-5313 for the treatment of Osteoarthritis; GB-7101 and GB-7103 for the treatment of prostate cancer; GB-6201 and GB-6203 for androgenetic alopecia treatments; and GH-001 for the treatment of Hepatitis B. It also develops GB-2001 for animal castration; and GB-2006, an animal postoperative pain relief drug, which is in clinical trial stage. The company was founded in 2017 and is headquartered in Cheongju-si, South Korea.
Show More
CEO
Mr. Hee-yong Lee Ph.D.
Country
South Korea
ISIN
KR7456160001
Listings
0 Comments
Share your thoughts
FAQs
What is G2GBIO stock price today?▼
The current price of 456160.KQ is ₩32,450 KRW — it has decreased by -10.36% in the past 24 hours. Watch G2GBIO stock price performance more closely on the chart.
What is G2GBIO stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange G2GBIO stocks are traded under the ticker 456160.KQ.
Is G2GBIO stock price growing?▼
456160.KQ stock has fallen by -17.11% compared to the previous week, the month change is a -25.57% fall, over the last year G2GBIO has showed a -46.36% decrease.
In which sector is G2GBIO located?▼
G2GBIO operates in the Other sector.
When did G2GBIO complete a stock split?▼
The last stock split for G2GBIO was on November 5, 2025 with a ratio of 2:1.
Where is G2GBIO headquartered?▼
G2GBIO is headquartered in Cheongju-si, South Korea.